SCHEMBL5156740

SCHEMBL5156740

COc1ccccc1C(=O)CCCc1ccccn1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2C19 P33261 1/20 0.59
RAB9A P51151 4/20 0.59
HDAC8 Q9BY41 1/20 0.54
HDAC1 Q13547 1/20 0.54
ALDH1A1 P00352 4/20 0.51
MAPK1 P28482 1/20 0.51
NPC1 O15118 3/20 0.49
MEN1 O00255 1/20 0.49
TP53 P04637 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 1/20 0.49
CTNNB1 P35222 4/20 0.48
WNT3A P56704 4/20 0.48
KDM4E B2RXH2 4/20 0.46
PKM P14618 1/20 0.46
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3696044 0.92 RAB9A (0.61) SMN1; SMN2CYP1A2CYP2C19RAB9AHDAC8
SCHEMBL15969585 0.79 CTNNB1 (0.67) SMN1; SMN2RAB9AHDAC8HDAC1NPC1
SCHEMBL15988867 0.79 RAB9A (0.58) SMN1; SMN2CYP2C19RAB9AHDAC8HDAC1
SCHEMBL7460882 0.78 HDAC8 (0.64) SMN1; SMN2RAB9AHDAC8HDAC1ALDH1A1
SCHEMBL15979734 0.77 CTNNB1 (0.71) SMN1; SMN2RAB9AHDAC8HDAC1ALDH1A1
SCHEMBL8569591 0.77 HDAC8 (0.67) SMN1; SMN2RAB9AHDAC8HDAC1ALDH1A1
SCHEMBL18163286 0.77 SMN1; SMN2 (0.60) SMN1; SMN2CYP1A2CYP2C19ALDH1A1MEN1
SCHEMBL6626765 0.76 HDAC8 (0.66) SMN1; SMN2HDAC8HDAC1ALDH1A1NPC1
SCHEMBL5311917 0.76 HDAC8 (0.66) HDAC8HDAC1ALDH1A1MAPK1NPC1
SCHEMBL15988824 0.76 CTNNB1 (0.59) SMN1; SMN2RAB9AHDAC8HDAC1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1126836-B1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2007-02-14 EP disclosed
EP-1126836-A4 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2002-09-04 EP disclosed
EP-1126836-A1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2001-08-29 EP disclosed
US-6194458-B1 1-(2-METHOXYPHENYL)-1-OXO-2-AZA-(S)-4-I-BUTYL-4-PHENYLBUTANE, FOR EXAMPLE; TREATING VARIOUS CONDITIONS INCLUDING TRANSPLANTATION REJECTION OF ORGANS OR TISSUES IN A PATIENT; IMMUNOSUPPRESSANT COMPOSITIONS MERCK & CO., INC. 2001-02-27 US disclosed
WO-2000025774-A1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2000-05-11 WO disclosed